Safety Events Common in Newly Approved Drugs

Nearly one third of drugs newly approved by the US Food and Drug Administration (FDA) are affected by safety issues that were not known at the time of approval, a study has shown.

Biologic and psychiatric drugs, as well as those that received accelerated approval or were approved within 60 days of the statutory decision deadline, are the most vulnerable to postmarket safety events, Nicholas S. Downing, MD, from the Department of Medicine at Brigham and Women's Hospital in Boston, Massachusetts, and colleagues report. Their study was published online May 9 in JAMA.

The findings "are not surprising to those of us who have been following this for a while, but they do reflect a growing realization by the mainstream medical community that there are important differences between efficacy in randomized controlled trials and effectiveness once a drug hits the real world," Peter J. Pitts told Medscape Medical News. Pitts is a former FDA associate commissioner and current president of the Center for Medicine in the Public Interest, New York, New York. "It reinforces the basic truth that when you give people medicine, interesting things will happen — good and bad. Postmarket research is the continual search for understanding what these interesting things are in the real world," he added.


 
Sign Up for Our Email Newsletter

RECENT NEWS

​Health Care Chutzpah vs. Health Plan Literacy

​Health Care Chutzpah vs. Health Plan Literacy

When patients complain that their prescription medicines are “too expensive,” what they generally mean is that their co-p...  Read more

America's health at stake

America's health at stake

The cuts to research funding would make it much harder for scientists to discover the cures of tomorrow. ...  Read more

Peter Pitts moderates CPAC Panel -  Promises Made, Promises Unkept: Time to get Serious About Healthcare

Peter Pitts moderates CPAC Panel - Promises Made, Promises Unkept: Time to get Serious About Healthcare

CPAC 2019 - Promises Made, Promises Unkept: Time to get Serious About Healthcare...  Read more

DRUGWONKS BLOG